DaltonTx is building the intelligence backbone for next-generation drug discovery, connecting AI models, experimental data, and lab workflows into a unified, continuously learning system.
Drug development today is fragmented - with disconnected models, siloed datasets, and slow feedback loops between computation and the lab. DaltonTx solves this by creating an orchestration layer that brings these components together, enabling a closed-loop process where insights flow seamlessly from in silico design to real-world validation and back again.
By integrating machine learning with experimental biology, DaltonTx allows researchers to design better therapeutics faster, prioritise the most promising candidates, and continuously improve outcomes through data-driven iteration. This is especially critical for complex biologics, where traditional approaches struggle to translate predictions into real-world success.
DaltonTx’s platform transforms drug discovery from a fragmented, trial-and-error process into a scalable, intelligent system - helping unlock the next generation of life-saving therapies.
